Lazard Asset Management LLC Homology Medicines, Inc. Transaction History

Lazard Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.91 - $1.69 $1,444 - $2,682	1,587 Added 21.84%	8,852 $8,000
Q4 2022 Feb 14, 2023	SELL	$1.09 - $2.04 $2,195 - $4,108	-2,014 Reduced 21.7%	7,265 $9,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $89 - $174	58 Added 0.63%	9,279 $14,000
Q2 2022 Aug 09, 2022	BUY	$1.39 - $3.12 $423 - $951	305 Added 3.42%	9,221 $17,000
Q1 2022 May 13, 2022	BUY	$2.6 - $4.17 $6,484 - $10,399	2,494 Added 38.84%	8,916 $26,000
Q4 2021 Feb 09, 2022	BUY	$3.64 - $7.78 $4,073 - $8,705	1,119 Added 21.1%	6,422 $22,000
Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $77,925 - $112,933	-12,966 Reduced 70.97%	5,303 $41,000
Q2 2021 Aug 12, 2021	BUY	$6.02 - $9.64 $109,040 - $174,609	18,113 Added 11610.9%	18,269 $131,000
Q4 2020 Feb 11, 2021	BUY	$8.92 - $13.29 $1,391 - $2,073	156 New	156 $1,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.